Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Funds

Offices

HQ
Hogi Tower
12 Abba Hillel Silver
St. Ramat Gan, 52506, ISR

People

CEO
CFO and Comptroller
Vice President
Vice President
Vice President
Vice President & General Counsel
Board of Director
Board of Director
Show All People

Tags

Clal Biotechnology

Clal Biotechnology Industries Ltd (CBI) is the largest biotechnology investment group in Israel. CBI targets promising companies with innovative bio-pharma technologies and transforms them into thriving and productive businesses.

Recent Milestones

Investments

Company Date Round Size Participants
CureTech 9/2013Private Equity$4M2
MediWound 6/2013Venture Round$18M1
Mnemosyne Pharmaceuticals 6/2013Series A$6M2
Avraham Pharmaceuticals 2/2013Private Equity$5.7M3
Gamida Cell 5/2012Series E$10M6
Avraham Pharmaceuticals 11/2011Venture Round$3M2
Avraham Pharmaceuticals 7/2010Series A$9M3
ProtAb 4/2010Series A$4M3
Aposense 8/2008Venture Round$7.3M9
Polyheal 1/2007Venture Round$1M1

Videos

Sources

  1. CureTech raises $4m in rights issue (globes.co.il) [edit]
  2. MediWound raises $18m (globes.co.il) [edit]
  3. Mnemosyne closes on additional $6M in Series A funding (pbn.com) [edit]
  4. Avraham Pharmaceuticals Raises $ 5.7M in Funding (finsmes.com) [edit]
  5. Gamida Cell Closes $10m Series E Financing (finsmes.com) [edit]
  6. Avraham Pharmaceuticals Closes $3M Financing (finsmes.com) [edit]
  7. Avraham Pharmaceuticals, Ltd.: Series A $9M (onbiovc.com) [edit]
  8. ProtAb has recently raised $4M from HBL and two of the largest life science venture capital firms in Israel, (hbl.co.il) [edit]
  9. Aposense Adds $7.3 Million (equityhelpdesk.com) [edit]
  10. Wound management co Polyheal raises $1m (ivc-online.com) [edit]
Edit This Page
Last Edited 2/24/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy